MTNB

Matinas BioPharma Holdings, Inc.

0.61

USD

MTNB Earnings Reports

Positive Surprise Ratio

MTNB beat 25 of 34 last estimates.

74%

Next Report

Date of Next Report

Apr 13, 2026

Estimate for Q4 25 (Revenue/ EPS)

Implied change from Q3 25 (Revenue/ EPS)

Implied change from Q4 24 (Revenue/ EPS)

Matinas BioPharma Holdings, Inc. earnings per share and revenue

On Nov 11, 2025, MTNB reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.

Looking ahead to Q4 25, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Takeda Pharmaceutical Company Limited - ADR

Report Date

Jan 30, 2026 For Q3 26

Estimate

$34.44

Actual

$65.64

Surprise

+90.61%

FAQ

What were Matinas BioPharma Holdings, Inc.'s earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Matinas BioPharma Holdings, Inc. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.

How did the market react to Matinas BioPharma Holdings, Inc.'s Q3 2025 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Matinas BioPharma Holdings, Inc. expected to report next?

The next earning report is scheduled for Apr 13, 2026.

What are the forecasts for Matinas BioPharma Holdings, Inc.'s next earnings report?

Based on -- analysts, Matinas BioPharma Holdings, Inc. is expected to report EPS of -- and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.